Metropolitan Life Insurance Company (MetLife)’s HealthEquity HQY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,468
| Closed | -$365K | – | 968 |
|
|
2024
Q1 | $365K | Sell |
4,468
-372
| -8% | -$29K | 0.02% | 534 |
|
|
2023
Q4 | $321K | Hold |
4,840
| – | – | 0.02% | 561 |
|
|
2023
Q3 | $354K | Buy |
4,840
+290
| +6% | +$19.6K | 0.02% | 512 |
|
|
2023
Q2 | $287K | Buy |
4,550
+65
| +1% | +$3.77K | 0.01% | 554 |
|
|
2023
Q1 | $263K | Sell |
4,485
-705
| -14% | -$42.8K | 0.01% | 581 |
|
|
2022
Q4 | $320K | Buy |
5,190
+179
| +4% | +$12K | 0.01% | 554 |
|
|
2022
Q3 | $337K | Hold |
5,011
| – | – | 0.02% | 541 |
|
|
2022
Q2 | $308K | Hold |
5,011
| – | – | 0.01% | 562 |
|
|
2022
Q1 | $338K | Sell |
5,011
-29,377
| -85% | -$1.59M | 0.01% | 612 |
|
|
2021
Q4 | $1.52M | Sell |
34,388
-1,369
| -4% | -$79.7K | 0.02% | 685 |
|
|
2021
Q3 | $2.32M | Sell |
35,757
-464
| -1% | -$32.2K | 0.03% | 441 |
|
|
2021
Q2 | $2.92M | Buy |
36,221
+633
| +2% | +$48.2K | 0.04% | 363 |
|
|
2021
Q1 | $2.42M | Buy |
35,588
+2,261
| +7% | +$178K | 0.04% | 432 |
|
|
2020
Q4 | $2.32M | Sell |
33,327
-1,265
| -4% | -$78.7K | 0.03% | 416 |
|
|
2020
Q3 | $1.78M | Buy |
34,592
+1,291
| +4% | +$70.9K | 0.03% | 462 |
|
|
2020
Q2 | $1.95M | Sell |
33,301
-4,767
| -13% | -$264K | 0.03% | 408 |
|
|
2020
Q1 | $1.93M | Sell |
38,068
-1,590
| -4% | -$106K | 0.04% | 396 |
|
|
2019
Q4 | $2.94M | Sell |
39,658
-551
| -1% | -$34.4K | 0.05% | 347 |
|
|
2019
Q3 | $2.3M | Buy |
40,209
+7,962
| +25% | +$528K | 0.04% | 438 |
|
|
2019
Q2 | $2.11M | Buy |
32,247
+684
| +2% | +$47.6K | 0.04% | 501 |
|
|
2019
Q1 | $2.34M | Sell |
31,563
-244
| -0.8% | -$17.2K | 0.04% | 409 |
|
|
2018
Q4 | $1.9M | Buy |
31,807
+201
| +0.6% | +$16.2K | 0.04% | 457 |
|
|
2018
Q3 | $2.98M | Buy |
31,606
+14,137
| +81% | +$1.22M | 0.05% | 321 |
|
|
2018
Q2 | $1.31M | Buy |
17,469
+2,045
| +13% | +$147K | 0.02% | 787 |
|
|
2018
Q1 | $934K | Sell |
15,424
-766
| -5% | -$41.5K | 0.01% | 935 |
|
|
2017
Q4 | $755K | Sell |
16,190
-17,678
| -52% | -$875K | 0.01% | 1034 |
|
|
2017
Q3 | $1.71M | Hold |
33,868
| – | – | 0.01% | 991 |
|
|
2017
Q2 | $1.69M | Buy |
33,868
+3,287
| +11% | +$154K | 0.01% | 1004 |
|
|
2017
Q1 | $1.3M | Sell |
30,581
-345
| -1% | -$15.3K | 0.01% | 1112 |
|
|
2016
Q4 | $1.25M | Sell |
30,926
-740
| -2% | -$28.6K | 0.01% | 1181 |
|
|
2016
Q3 | $1.2M | Hold |
31,666
| – | – | 0.01% | 1189 |
|
|
2016
Q2 | $962K | Buy |
31,666
+6,137
| +24% | +$161K | 0.01% | 1277 |
|
|
2016
Q1 | $630K | Hold |
25,529
| – | – | ﹤0.01% | 1446 |
|
|
2015
Q4 | $640K | Hold |
25,529
| – | – | ﹤0.01% | 1464 |
|
|
2015
Q3 | $754K | Hold |
25,529
| – | – | 0.01% | 1349 |
|
|
2015
Q2 | $818K | Buy |
+25,529
| New | +$685K | 0.01% | 1422 |
|
|
2015
Q1 | – | Sell |
-8,871
| Closed | -$226K | – | 2301 |
|
|
2014
Q4 | $226K | Sell |
8,871
-5,899
| -40% | -$128K | ﹤0.01% | 2328 |
|
|
2014
Q3 | $270K | Buy |
+14,770
| New | +$284K | ﹤0.01% | 2161 |
|
Other funds holding HQY
WA
Metropolitan Life Insurance Company (MetLife)'s HQY Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of HealthEquity (HQY) in Q2 2024, closing a stake of 4,468 shares — an estimated $365K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in HQY in Q3 2014 and held it in 38 quarters. The position peaked at $2.98M in Q3 2018. 386 funds tracked by Wall St. Rank hold HQY as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining HealthEquity position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 4,468 HealthEquity shares in Q2 2024, an estimated $365K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in HealthEquity in Q3 2014 and held it in 38 quarters.
- Metropolitan Life Insurance Company (MetLife)'s HealthEquity position peaked at $2.98M in Q3 2018.
- 386 funds tracked by Wall St. Rank held HealthEquity as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.